Enliven Therapeutics to Present at the Jefferies London Healthcare Conference
Rhea-AI Summary
Enliven Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in the Jefferies London Healthcare Conference on November 19, 2024, at 9:30 a.m. GMT. The company's management will engage in a fireside chat, which will be webcast live. Interested parties can access the webcast via the investor relations section of Enliven's website. The webcast will remain available for 90 days post-event.
Positive
- None.
Negative
- None.
News Market Reaction – ELVN
On the day this news was published, ELVN declined 0.14%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at https://ir.enliventherapeutics.com/. The webcast will be archived for a period of 90 days following the conclusion of the live event.
About Enliven
Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people with cancer not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall well-being. Enliven's discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. Enliven is based in
View original content to download multimedia:https://www.prnewswire.com/news-releases/enliven-therapeutics-to-present-at-the-jefferies-london-healthcare-conference-302299207.html
SOURCE Enliven Therapeutics, Inc.
FAQ
When will Enliven Therapeutics participate in the Jefferies London Healthcare Conference?
How can I access the Enliven Therapeutics fireside chat webcast from the Jefferies London Healthcare Conference?
How long will the Enliven Therapeutics webcast be available after the Jefferies London Healthcare Conference?
What is the stock symbol for Enliven Therapeutics?
